Detalhe da pesquisa
1.
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 537-551, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38337035
2.
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 578, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38360936
3.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
; 54(10): 2399-2416.e6, 2021 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34481543
4.
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.
Immunity
; 54(9): 2159-2166.e6, 2021 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34464596
5.
Defining the risk of SARS-CoV-2 variants on immune protection.
Nature
; 605(7911): 640-652, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35361968
6.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
; 596(7870): 103-108, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34153975
7.
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
J Virol
; 98(3): e0120623, 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38305154
8.
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
J Virol
; 98(5): e0190323, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38593045
9.
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
J Virol
; 97(9): e0062823, 2023 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37676002
10.
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol
; 97(6): e0063523, 2023 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37223945
11.
COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.
Brain
; 145(12): 4193-4201, 2022 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36004663
12.
Therapeutic efficacy of favipiravir against Bourbon virus in mice.
PLoS Pathog
; 15(6): e1007790, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31194854
13.
Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.
J Virol
; 93(22)2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31462571
14.
Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer.
PLoS Pathog
; 14(4): e1007001, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29698474
15.
Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.
J Immunol
; 192(8): 3465-9, 2014 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24639356
16.
CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-ß.
J Immunol
; 191(6): 3082-9, 2013 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23956428
17.
Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
Res Sq
; 2024 Feb 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38405749
18.
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19.
bioRxiv
; 2024 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38405752
19.
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.
bioRxiv
; 2023 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37205409
20.
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.
bioRxiv
; 2023 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37205450